Bioequivalence of Dapagliflozin 10 mg Tablets Under Fasting Conditions

PHASE1CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

December 14, 2020

Primary Completion Date

December 24, 2020

Study Completion Date

February 4, 2021

Conditions

Healthy Subjects

Interventions

DRUG

Dapagliflozin 10 mg tablets

Manufactured by Jiangsu Hansoh Pharmaceutical Group Co., Ltd

DRUG

Farxiga® 10 mg tablets

Manufactured by AstraZeneca Pharmaceuticals LP

Trial Locations (1)

Pharma Medica Research Inc., Toronto